Under Dr. Grossman’s leadership, the health system now features six inpatient locations, more than 300 outpatient sites across Florida and the New York area and the Perlmutter Cancer Center in New York City, according to a June 12 NYU Langone statement shared with Becker’s.
Since Dr. Grossman’s tenure began in 2007, the health system has increased revenue from $2 billion in 2007 to over $12 billion in 2023.
“It is immensely gratifying to know that we have transformed NYU Langone Health into an institution that is simply nonpareil!” Dr. Grossman wrote in a message sent to the NYU Langone community, according to the release.
Kenneth Langone has also shared plans to retire from his role as chair of the NYU Langone Board of Trustees around the time of Dr. Grossman’s retirement, but will stay on as a board member. Fiona Druckenmiller will succeed Mr. Langone as Chair of the NYU Langone Board of Trustees.
A national search will begin soon to find a successor for Dr. Grossman.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
